We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 405.00
Bid: 400.00
Ask: 410.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.50%)
Open: 405.00
High: 405.00
Low: 405.00
Prev. Close: 405.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

10 Feb 2009 07:00

RNS Number : 0465N
Avingtrans PLC
10 February 2009
 



Embargoed Release: 07:00hrs 10th February 2009

Avingtrans plc

("Avingtrans" or the "Group")

Interim results for the six months ended 30 November 2008

Avingtrans plc, which designs, manufactures and supplies critical components and associated services to the medical, energy, industrial and global aerospace sectors, today announces its interim results for the six months ended 30 November 2008.

Financial Highlights

Turnover decreased by 17% to £17.5m (2008:£21.1m)

Gross profit margin improved to 28% (2008: 26%) 

Operating profit margin sustained at 5%

Fully diluted, adjusted1 EPS of 2.1 pence per share (2008: 4.2 pence per share) 

Cash generated from operations, at £1.9m, significantly better than last year (2008: £0.5m)

Continued new investment of £1.3m in the business during the period

Net debt reduced by 31% to £7.5m (31 May 2008: £10.8m) post the successful placing

1 - fully diluted earnings per share adjusted to add back amortisation and exceptional items

Operational highlights

The Industrial Products Division continues its robust performance with revenues up 22% compared to 2007 and EBIT up 53%. It has received its first significant order from China, securing an estimated £1.8m, five year contract with a major machine tools manufacturer.

Whilst the Energy and Medical Division has seen year on year reductions from Siemens, the business has stabilised and management has successfully negotiated new contract terms and conditions for on-going supply of MRI equipment.

A major £4m Oil and Gas project expected to complete on time by financial year end

In Aerospace, Sigma China has not progressed as quickly as planned, however:

New local management resolving operational issues

Sigma received its first order from GE China 

Planned expansion of the facilities is underway.

Pipeline of prospects across all divisions remains promising

Commenting on the results, Roger McDowell, Chairman, said:

"The first half of the year proved challenging for the Group. However, whilst we acknowledge that conditions are likely to remain challenging, we remain confident in the robustness of the Group's core businesses and believe that actions taken and planned will enable the Group to deliver improved profitability for the year ended 31 May 2009 over the previous financial year". 

Enquiries:

 

Avingtrans plc tel. 01159 499 020 

Roger McDowell, Chairman 

Steve McQuillan, Chief Executive Officer

Stephen King, Finance Director 

 

KBC Peel Hunt Ltd tel. 020 7418 8900 

Julian Blunt / Matthew Tyler

Hansard Group  tel. 020 7245 1100 

Adam Reynolds / John Bick

About Avingtrans plc www.avingtrans.plc.uk

Avingtrans plc is engaged in the provision of precision engineering components and services to the energy, medical, scientific and research communities, traffic management, automation, machinery and aerospace industries worldwide. It is organized in three business segments: 

Aerospace, which is engaged in the manufacture of rigid pipe assemblies and prismatic components for aero engines and precision finishing of aircraft components 

Energy and Medical, engaged in the manufacture of machined and fabricated pressure and vacuum vessels and components for the energy, medical, science and research communities and design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling

Industrial products, which is engaged in the design, manufacture, distribution and service of precision ballscrews, spindles and related linear and rotary products servicing the original equipment and after markets in global industry.

Chairman's Statement

The Group's financial performance has been strongly challenged by global market conditions and, overall, we have seen a mixed picture in our trading so far this year, although we have made substantial progress increasing efficiencies across the business. Notwithstanding short term difficulties, we believe our strategy of building market-leading, niche positions in our defined market sectors will prove to be robust and we continue to pursue it with vigour.

Although Group revenues are down £3.6m compared with the first half of last year, we have cut costs accordingly in all areas to maintain profitability and expect performance to significantly improve in the second half. However, the improvement will not be enough to match our previous expectations, though we still believe we will be ahead of last year. We remain very guardedly optimistic about our prospects throughout the global economic downturn, with a significant pipeline of opportunities developing, albeit rather more slowly than we previously envisaged.

 

The refreshed management team has the capability to act quickly, as needs arise, to ensure that the Group remains competitive under changing market conditions and is focusing on improving returns for shareholders. Executing our strategy will enable us to deliver strong value growth in future and we believe that our market positions will enable us to come out of the current cycle poised for future growth. 

Roger McDowell

Chairman

10 February 2009

Business Review

Group Performance

As anticipated, Group revenue was lower in this half year, coming in at £17.5m (2008: £21.1m). The decrease was mainly down to year on year reductions at Metalcraft associated with the reduced volume of business from Siemens and reduced volumes at Crown, pending approvals of the new SmartPoleTM product.

Consequently, operating profit was also down, at £885k (2008: £1,355k). However, we had always expected a strong skew between the first and second half, due to the significant impact of a £4m Oil and Gas project that Metalcraft still expects to complete on time by financial year end. This project also produced a significant skew in inventories and creditors in the first half which will be regularised on completion. An additional impact was from Sigma Chinabehind expectations, but new local management is resolving operational issues and expansion of facilities has commenced.

Adjusted diluted earnings per share, for the period ending 30 November 2008, was 2.1p (2008: 4.2p).

Funding and Liquidity

The net cashflow from operations was £1,892k (2008: £538k).

Net indebtedness at 30 November 2008 stood at £7.5m, £3.3m lower than at the prior year end. Balance sheet gearing was 38.2%, down from 66.8% at 31 May 2008.

Taxation

As reported in the 2008 Annual Report, following the Finance Act 2008 receiving Royal Assent, the withdrawal of industrial building allowances gives rise to an additional tax charge of £367k for the year ending 31 May 2009. This exceptional charge has been recognised in full at the half year and, thus, creates the loss in the period.

 

Dividend

The Board believes it is prudent to preserve cash in the business at this time and, consequently, recommends that no dividend should be paid in respect of the half year (2008: 0.5p). Looking forward, the Board will keep the year end dividend under review, taking account of the on-going changes in trading position in our markets.

Operations

The Energy and Medical Division has seen a reduction in overall business this year, as the Siemens contract stabilises at a lower level than hitherto. We successfully concluded negotiations with Siemens concerning new long term contract terms and conditions, including a new agreement on pricing for 18 months, lasting until April 2010. 

There has been positive movement on the Metalcraft China facility, with our launch customer ready to commence production during 2009. 

Prospects in the energy sector remain strong, though the timing of these projects is more difficult to predict; oil price volatility being one key item impacting the phasing of our forward order pipeline. Nuclear sector prospects are also promising, with positive indications on repeat nuclear decommissioning and replacement reprocessing business. Metalcraft has been named as preferred bidder in an enabling contract with Magnox North for commissioning drums for intermediate level waste storage.

The large scale (£4m) Oil and Gas project that we reported on in the last annual report remains on-track for completion by the end of this financial year. 

Concerning the Marine sector for pressure vessel equipment, Metalcraft successfully completed 4 diving bells for UK customers and 2 submersible pressure hulls for Far Eastern navies.

Crown UK has received the first test orders for its next generation pole design, including first orders from Redflex Europe, with more expected to follow once the qualification processes are complete. However, order volumes have reduced in the past few months, as OEMs seek to minimise stock positions in anticipation of standardising on the new design, currently undergoing Home Office approval. 

Industrial Products has had a very good half year, with revenues up 22% compared with last year. The division is delivering its strategy of developing niche high precision engineered components, coupled with a diversification of its product strategy to include factored products and related equipment, as well as the increase of its production capacity linked to recent investments.

However, we are seeing softening in the global machine tools market, though we do not expect this to materially impact the results of the division in the current financial year. As recently announced, the division is making good progress in developing its Asian business - notably with a significant contract in China - and a number of other geographical sales channels are under development also.

In February 2009, we acquired the assets of the Moss Group for a total consideration of £90k. This fits nicely into the strategy of Jena in the UK, providing access to the servicing and repair aftermarket and specialist machine attachments that compliment the division's high precision Jena Tec product range.

The Aerospace Division has been a hive of activity in the last six months. Following the successful placing in October 2008, we have begun to increase the investment in our Chinese business, Sigma, albeit more cautiously in light of the global events over the last few months. The next batch of new machines for the facility is due in the near future and we expect this to enable a substantial increase in capacity.

Sigma continued to grow its order book, gaining approval from GE in SuzhouChina, and securing first orders. Overall, the order book has not developed as fast as we envisaged in China, with a number of prospects delaying decisions due to their own internal issues. As a result, Sigma's volumes are lower than expected and it has not yet broken into profit. Overall, Sigma is behind our first half expectations and new local management is addressing the operational issues to improve performance. Strong interest in our Chinese capability continues to be expressed by a number of major aerospace customers and we still believe that increased orders will allow us to achieve profitability in the coming months.

The B&D Patterns business has continued to improve operationally, though the performance has been tempered by the softening of orders from some of our main customers in the commercial aerospace sector. The cost base of the business has been trimmed accordingly, including consolidating operations onto a single site and we believe that it is now correctly sized for the weaker conditions in the market. Discussions continue on the warranty claim with the former owners of B&D.

C&H had a reasonable six months overall, though they too are seeing some softening in demand, as the aerospace supply chain adjusts to lighter forward order books than in recent years. The new C&H facility in Cheltenham ramped up capacity successfully, providing a range of polishing services, principally to Messier Dowty.

Outlook

Given the current global economic environment, there are inevitably increasing risks of reduced demand in Aerospace and Industrial Products. However, the actions that we are taking to cut costs and insulate ourselves strategically from the changes should provide some degree of resilience to our activity levels within these sectors. Conversely, Energy and Medical is expected to be more stable overall, though a degree of agility is required on our part to adjust to changing conditions in the various sub-sectors that we compete in.

Taking everything into account, whilst we now expect to be below where we anticipated at the start of the financial year, we expect to improve on the Group's profitability for the year ended 31 May 2009 compared to 2008. 

In summary, our strategy to focus on niches where we can differentiate our offering will offer some protection to cyclical market exposure, but we cannot assume that we will be able to fully mitigate the current downward trend. Overall, Avingtrans is well placed to benefit from structural changes in our markets and to grow as global industrial markets recover.

Roger McDowell Steve McQuillan Stephen King

Chairman Chief Executive Finance Director

10 February 2009 10 February 2009 10 February 2009

Consolidated Income Statement (Unaudited)

for the six months ended 30 November 2008

6 months to

6 months to

Year to

30 Nov

2008

30 Nov

2007

31 May

2008

£'000

£'000

£'000

Revenue 

17,527

21,137

41,247

Cost of sales

(12,587)

(15,742)

(30,324)

Gross profit

4,940

5,395

10,923

Distribution costs

(479)

(486)

(944)

Administrative expenses

(3,576)

(3,554)

(7,249)

Operating profit before share based payments and amortisation / impairment of intangibles

885

1,355

2,730

Share based payment expense

(18)

(20)

(25)

Amortisation of intangibles from business combinations

(69)

(128)

(137)

Operating profit 

798

1,207

2,568

Finance income

-

5

6

Finance costs

(381)

(414)

(880)

Profit before taxation

417

798

1,694

Taxation  (Note 3) 

(475)

(196)

(549)

(Loss)/profit for the financial year

(58)

602

1,145

(Loss)/earnings per share :

From continuing operations

- Basic

(0.2)p

3.4p

6.5p

- diluted

(0.2)p

3.4p

6.4p

All the above results are from continuing operations

Consolidated statement of total recognised income and expense (Unaudited)

for the six months ended 30 November 2008

6 months to

6 months to

Year to

30 Nov

2008

30 Nov

2007

31 May

2008

£'000

£'000

£'000

Exchange differences on translation of foreign operations

240

124

335

Net movement recognised directly in equity

240

124

335

Loss for the period

(58)

602

1,145

Total recognised income and expense for the period

182

726

1,480

Consolidated cash flow statement (Unaudited)

for the six months ended 30 November 2008

6 months to

6 months to

Year to

30 Nov

2008

30 Nov

2007

31 May

2008

£'000

£'000

£'000

Operating activities

Cash flows from operating activities

1,892

538

2,819

Finance costs paid

(382)

(417)

(902)

Income tax paid

(34)

(235)

(757)

Net cash inflow/(outflow) from operating activities

1,476

(114)

1,160

Investing activities

Interest received

-

5

6

Acquisition of subsidiaries

-

-

(16)

Acquisition of investment

-

(215)

(219)

Purchase of intangible assets

(90)

(87)

(411)

Purchase of property, plant and equipment

(1,178)

(201)

(607)

Proceeds from sale of property, plant and equipment

15

1

53

Proceeds from sale of investments

-

19

19

Net cash used in investing activities

(1,253)

(478)

(1,175)

Financing activities

Dividends paid

(132)

(131)

(220)

Repayments of borrowings

(302)

(629)

(1,044)

Repayments of obligations under finance leases

(545)

(423)

(873)

Proceeds from issue of ordinary shares

3,358

33

34

Borrowings raised

469

239

869

Net cash inflow/(outflow) from financing activities

2,848

(911)

(1,234)

Net increase/(decrease) in cash and cash equivalents

3,071

(1,503)

(1,249)

Cash and cash equivalents at beginning of period

(2,534))

(1,302)

(1,302)

Effect of foreign exchange rate changes

(89)

66

17

Cash and cash equivalents at end of year

448

(2,739)

(2,534)

Cash generated from operations: 

for the six months ended 30 November 2008

6 months to

6 months to

Year to

30 Nov

2008

30 Nov

2007

31 May

2008

£'000

£'000

£'000

Continuing operations

Profit before income tax

417

798

1,694

Adjustments for:

Depreciation

706

673

1,287

Amortisation and impairment of Intangible assets

92

128

227

(Profit) on disposal of property, plant and equipment

(11)

(7)

(20)

(Profit) on disposal /impairment of investment

-

-

(7)

Finance income

-

(5)

(6)

Finance expense

381

414

880

Share based payment charge

18

20

25

Changes in working capital

(Increase) in inventories

(1,978)

(519)

(327)

(Increase)/decrease in trade and other receivables

(515)

1,188

1,660

Increase/(decrease) in trade and other payables

2,773

(2,171)

(2,619)

Other non cash charges

9

19

25

Cashflows from operating activities

1,892

538

2,819

Summarised consolidated balance sheet (Unaudited)

at 30 November 2008

30 Nov

30 Nov

31 May

2008

2007

2008

£'000

£'000

£'000

Non current assets

Goodwill

10,242

10,226

10,242

Other intangible assets

1,817

1,538

1,784

Property, plant and equipment

10,991

10,694

10,560

Deferred tax

24

-

24

Investments

219

215

219

23,293

22,673

22,829

Current assets

Inventories

8,636

6,538

6,480

Trade and other receivables

7,557

7,731

6,984

Current tax asset

119

-

196

Cash and cash equivalents

2,533

1,058

548

18,845

15,327

14,208

Total assets

42,138

38,000

37,037

Current liabilities

Trade and other payables

(9,910)

(7,747)

(7,278)

Obligations under finance leases

(926)

(701)

(935)

Borrowings

(2,585)

(4,949)

(3,591)

Current tax liabilities

(492)

(824)

(489)

Total current liabilities 

(13,913)

(14,221)

(12,293)

Non-current liabilities

Borrowings

(4,749)

(4,800)

(5,034)

Obligations under finance leases

(1,762)

(1,788)

(1,789)

Deferred tax

(1,370)

(945)

(1,003)

Deferred consideration

(750)

(750)

(750)

Total non-current liabilities

(8,631)

(8,283)

(8,576)

Total liabilities

(22,544)

(22,504)

(20,869)

Net assets

19,594

15,496

16,168

Equity

Share capital

1,232

882

882

Share premium account

9,280

6,271

6,272

Capital redemption reserve

814

814

814

Merger reserve

402

402

402

Translation reserve

538

87

298

Other reserves

180

180

180

Retained earnings

7,148

6,860

7,320

Total equity attributable to equity holders of the parent

19,594

15,496

16,168

Notes to the half year statement

30 November 2008

1. Basis of preparation

The Group's interim results for the six month period ended 30 November 2008 are prepared in accordance with the Group's accounting policies which are based on the recognition and measurement principles of International Financial Reporting Standards ('IFRS') as adopted by the EU and effective, or expected to be adopted and effective, at 31 May 2009. As permitted, this interim report has been prepared in accordance with the AIM rules and not in accordance with IAS34 'Interim financial reporting'.

These interim results do not constitute full statutory accounts within the meaning of section 240(5) of the Companies Act 1985 and are unaudited. The unaudited interim financial statements were approved by the Board of Directors on 9 February 2009and will shortly be available on the Group's website at

 

http://www.avingtrans.plc.uk/pages/reports.html.

The consolidated financial statements are prepared under the historical cost convention as modified to include the revaluation of financial instruments. The accounting policies used in the interim financial statements are consistent with IFRS and those which will be adopted in the preparation of the Group's annual report and financial statements for the year ended 31 May 2009. The statutory accounts for the year ended 31 May 2008, which were prepared under IFRS, have been filed with the Registrar of Companies. These statutory accounts carried an unqualified Auditors' Report and did not contain a statement under either Section 237(2) or (3) of the Companies Act 1985.

2. Segmental analysis

Aerospace

Energy and

Medical

Industrial

Products

Unallocated

Central

items

Total

£'000

£'000

£'000

£'000

£'000

6 months ended 30 Nov 2008

Revenue

5,576

7,342

4,609

-

17,527

Operating profit

3

315

617

(137)

798

Year ended 31 May 2008

Revenue

12,333

20,863

8,051

-

41,247

Operating profit

484

1,492

808

(216)

2,568

6 months ended 30 Nov 2007

Revenue

6,005

11,365

3,767

-

21,137

Operating profit

162

806

402

(163)

1,207

3. Taxation

As reported in the 2008 Annual Report, following the Finance Act 2008 receiving Royal Assent the withdrawal of industrial building allowances gives rise to an additional deferred tax charge of £367k for the year ending 31 May 2009. The taxation charge is based upon the expected rate for the year ended 31 May 2009. 

4. (Loss)/earnings per share

Basic earnings per share is based on the earnings attributable to ordinary shareholders and the weighted average number of ordinary shares in issue during the year.

For diluted earnings per share the weighted average number of ordinary shares is adjusted to assume conversion of all dilutive potential ordinary shares, being the warrants and EMI share options.

6 months to 

30 Nov 2008

No

6 months to 

30 Nov 2007

No 

Year to 

31 May 2008

No

Weighted average number of shares - basic

18,493,591

17,579,184

17,604,810

Warrant/ Share Option adjustment

24,481

249,435

174,615

Weighted average number of shares - diluted

18,518,072

17,828,619

17,779,425

£'000

£'000

£'000

(Loss)/earnings attributable to shareholders

(58)

602

1,145

Share based payments

18

20

25

Amortisation of intangibles

69

128

137

Deferred tax charge re abolition of UK IBA's

367

-

-

Adjusted earnings attributable to shareholders

396

750

1,307

Basic earnings per share 

(0.2)p

3.4p

6.5p

Diluted earnings per share 

(0.2)

3.4p

6.4p

Adjusted basic earnings per share 

2.1p

4.3p

7.4p

Adjusted diluted earnings per share 

2.1p

4.2p

7.4p

 

The Directors believe that the above adjusted earnings per share calculation is a more appropriate reflection of the Group performance. Owing to loss reported in the 6 months ended 30 November 2008 the share options and warrants are not dilutive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR CKCKKFBKDPBK
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.